(Q35616803)
Statements
A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma (English)
Beatrice Seddon
Michelle Scurr
Zoe Wood
Cerys Propert-Lewis
Cyril Fisher
Adrienne Flanagan
Jonanthan Sunkersing
Roger A'Hern
Jeremy Whelan
1 reference